Informing Patients About Their Surgery's Environmental Impact: an Effective Pathway to Sustainable Healthcare?
2 other identifiers
interventional
400
1 country
1
Brief Summary
The healthcare sector contributes significantly to climate change. Reducing the number of patients receiving resource-intensive procedures such as surgery can lower carbon emissions, particularly when two treatments with comparable clinical outcomes are available. Nevertheless, the impact of incorporating environmental considerations into patients' decision-making processes remains underexplored. The investigators examine how including information about the environmental impact of treatment options in a gallstone decision aid affects patients' real-life choice between surgery and the more sustainable alternative of conservative treatment. Moreover, the investigators examine whether factors such as severity of symptoms moderate the relation between sustainability information and patients' treatment choice. An exploratory vignette study informed the hypotheses that will be tested among actual patients with gallstones making actual treatment decisions. The results of this ecologically valid study have implications for both clinical practice and healthcare policy by offering insight into the effectiveness of pathways to include patients in the transition towards sustainable healthcare.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2026
CompletedFirst Posted
Study publicly available on registry
April 1, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
April 1, 2026
March 1, 2026
1 year
March 20, 2026
March 25, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Treatment preference (surgery or wait-and-see)
The primary outcome is treatment preference. Specifically, participants will indicate their treatment preference by selecting either the option 'Surgery' or 'Wait and see' (dichotomous variable)
baseline, pre-intervention
Secondary Outcomes (2)
Treatment certainty
baseline, pre-intervention
Treatment decision
Assessment 3 months after the participants receive the decision aid
Study Arms (2)
Intervention condition
EXPERIMENTALIntervention condition, in which a decision aid includes a page with information about the environmental impact of surgical removal of the gallbladder.
Control condition
NO INTERVENTIONA control condition, which includes no information on sustainability in the decision aid.
Interventions
The intervention decision aid includes a page with information about the environmental impact of surgical removal of the gallbladder, and a control condition, which includes no such information. Besides information about the environmental impact of gallbladder surgery, the intervention and control conditions will be identical. At the end of the decision aid patients will be debriefed in general phrasing (i.e., the aim of this study was to examine which factors affect treatment choice) to prevent influencing the actual decision. Approximately three months after patients received the decision aid, patients will receive an invitation via the PatientPlus portal to complete a survey in which the investigators inquire about their final treatment decision (first reminder after one week, second reminder after two weeks). At the end of this survey, patients will be debriefed about the aim of examining how information about the environmental impact of surgery affects treatment choice.
Eligibility Criteria
You may qualify if:
- Patients who were referred to three participating hospitals located across the Netherlands
- Patients who received PatientPlus' gallstone decision aid in preparation for their surgical consultation
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Amsterdamlead
- Radboud University Medical Centercollaborator
- Leiden University Medical Centercollaborator
Study Sites (1)
University of Amsterdam
Amsterdam, North Holland, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Since random allocation is not feasible due to technical limitations, the investigators will alternate conditions (control versus intervention) approximately every 50 patients. PatientPlus (provider of decisoin aid) will collect the data and the analyst will remain blind to condition labels until all primary analyses are completed. This ensures that the analyses will be performed blind to experimental conditions.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoctoral researcher
Study Record Dates
First Submitted
March 20, 2026
First Posted
April 1, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
April 1, 2026
Record last verified: 2026-03